By G HossainPosted on March 18, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Protagonist Therapeutics will now sit back and collect cash from the J&J partnership, including an immediate $50 million payment. Protagonist’s First Approval Spells Trouble for Pharma’s Immunology Heavyweights Post navigation Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning LetterTerraPower Commits $450M to Build Radioisotope Production Plant